Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis

被引:22
作者
Lee, Soon Kyu [1 ]
Song, Myeong Jun [1 ]
Kim, Seok Hwan [1 ]
Ahn, Hyo Jun [1 ]
机构
[1] Catholic Univ Korea, Daejeon St Marys Hosp, Coll Med, Div Hepatol,Dept Internal Med, 64 Daeheung Ro, Daejeon 34943, South Korea
关键词
Liver cirrhosis; Diastolic heart failure; Cardiomyopathies; Echocardiography; C-REACTIVE PROTEIN; NATRIURETIC PEPTIDE; CARDIOVASCULAR DYSFUNCTION; INTERVAL PROLONGATION; HOSPITALIZED-PATIENTS; RECOMMENDATIONS; CARDIOMYOPATHY; PREVALENCE; SEVERITY;
D O I
10.3350/cmh.2018.0034
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Left ventricular diastolic dysfunction (LVDD) is an early manifestation of cardiac dysfunction in patients with liver cirrhosis (LC). However, the effect of LVDD on survival has not been clarified, especially in decompensated LC. Methods: We prospectively enrolled 70 patients with decompensated LC, including ascites or variceal bleeding, at Daejeon St. Mary's Hospital from April 2013 to April 2015. The cardiac function of these patients was evaluated using 2D echocardiography with tissue Doppler imaging. The diagnosis of LVDD was based on the American Society of Echocardiography guidelines. The primary endpoint was overall survival. Results: Forty-four patients (62.9%) had LVDD. During follow-up (22.3 months), 18 patients died (16 with LVDD and 2 without LVDD). The survival rate was significantly lower in patients with LVDD than in those without LVDD (31.1 months vs. 42.6 months, P=0.01). In a multivariate analysis, the Child-Pugh score and LVDD were independent predictors of survival. Moreover, patients with a ratio of early filling velocity to early diastolic mitral annular velocity (E/e') >= 10 (LVDD grade 2) had lower survival than patients with E/e' ratio < 10. Conclusions: The presence of LVDD is associated with poor survival in patients with decompensated LC. Therefore, it may be important to monitor and closely follow LVDD patients.
引用
收藏
页码:409 / 416
页数:8
相关论文
共 26 条
[1]   Q-T interval prolongation in cirrhosis: Prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors [J].
Bernardi, M ;
Calandra, S ;
Colantoni, A ;
Trevisani, F ;
Raimondo, ML ;
Sica, G ;
Schepis, F ;
Mandini, M ;
Simoni, P ;
Contin, M ;
Raimondo, G .
HEPATOLOGY, 1998, 27 (01) :28-34
[2]  
Bernardi M, 2012, EXPERT REV GASTROENT, V6, P57, DOI [10.1586/egh.11.86, 10.1586/EGH.11.86]
[3]   Diastolic Dysfunction in Liver Cirrhosis: Prognostic Predictor in Liver Transplantation? [J].
Carvalheiro, F. ;
Rodrigues, C. ;
Adrego, T. ;
Viana, J. ;
Vieira, H. ;
Seco, C. ;
Pereira, L. ;
Pinto, F. ;
Eufrasio, A. ;
Bento, C. ;
Furtado, E. .
TRANSPLANTATION PROCEEDINGS, 2016, 48 (01) :128-131
[4]   Prognostic value of C-reactive protein levels in patients with cirrhosis [J].
Di Martino, Vincent ;
Coutris, Caroline ;
Cervoni, Jean-Paul ;
Dritsas, Stavros ;
Weil, Delphine ;
Richou, Carine ;
Vanlemmens, Claire ;
Thevenot, Thierry .
LIVER TRANSPLANTATION, 2015, 21 (06) :753-760
[5]   Diastolic dysfunction diagnosed by tissue Doppler imaging in cirrhotic patients: Prevalence and its possible relationship with clinical outcome [J].
Falletta, Calogero ;
Fili, Daniela ;
Nugara, Cinzia ;
Di Gesaro, Gabriele ;
Mina, Chiara ;
Baravoglia, Cesar Mario Hernandez ;
Romano, Giuseppe ;
Scardulla, Cesare ;
Tuzzolino, Fabio ;
Vizzini, Giovanni ;
Clemenza, Francesco .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2015, 26 (10) :830-834
[6]  
Fede G, 2015, ANN GASTROENTEROL, V28, P31
[7]   The changing role of beta-blocker therapy in patients with cirrhosis [J].
Ge, Phillip S. ;
Runyon, Bruce A. .
JOURNAL OF HEPATOLOGY, 2014, 60 (03) :643-653
[8]  
Ha Jong-Won, 2009, J Cardiovasc Ultrasound, V17, P86, DOI 10.4250/jcu.2009.17.3.86
[9]   Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease [J].
Henriksen, JH ;
Gotze, JP ;
Fuglsang, S ;
Christensen, E ;
Bendtsen, F ;
Moller, S .
GUT, 2003, 52 (10) :1511-1517
[10]   The clinical course of cirrhosis: The importance of multistate models and competing risks analysis [J].
Jepsen, Peter ;
Vilstrup, Hendrik ;
Andersen, Per Kragh .
HEPATOLOGY, 2015, 62 (01) :292-302